It is a decentralized system for verifying that the parties to a transaction have the money they claim to have, eliminating the need for traditional intermediaries, such as banks, when funds are being transferred between two entities. : 18Ī cryptocurrency, crypto-currency, or crypto is a digital currency designed to work as a medium of exchange through a computer network that is not reliant on any central authority, such as a government or bank, to uphold or maintain it. This note has been interpreted as a comment on the instability caused by fractional-reserve banking. 241000894007 species Species 0.The genesis block of Bitcoin's blockchain, with a note containing The Times newspaper headline.239000007983 Tris buffer Substances 0.000 claims description 5.229910020820 NaAc-HAc Inorganic materials 0.000 claims description 5.230000014759 maintenance of location Effects 0.000 claims description 8.239000012149 elution buffer Substances 0.000 claims description 12.238000005341 cation exchange Methods 0.000 claims description 15.239000007853 buffer solution Substances 0.000 claims description 21.238000010828 elution Methods 0.000 claims abstract description 15.230000002378 acidificating Effects 0.000 claims abstract description 21.238000005277 cation exchange chromatography Methods 0.000 claims abstract description 30.108090001123 antibodies Proteins 0.000 claims abstract description 47.102000004965 antibodies Human genes 0.000 claims abstract description 48.229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 title 1.108010045030 monoclonal antibodies Proteins 0.000 title claims description 30.102000005614 monoclonal antibodies Human genes 0.000 title claims description 30.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by WANLE PHARMACEUTICAL CO Ltd SHENZHEN filed Critical WANLE PHARMACEUTICAL CO Ltd SHENZHEN Priority to CN201610901017.3A priority Critical patent/CN106380519B/en Publication of CN106380519A publication Critical patent/CN106380519A/en Application granted granted Critical Publication of CN106380519B publication Critical patent/CN106380519B/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Original Assignee WANLE PHARMACEUTICAL CO Ltd SHENZHEN Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
( en Inventor 李乐 郭秋菊 蒙国基 邓义熹 张铭生 李雪 于玉根 Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number CN201610901017.3A Other languages Chinese ( zh)
#Capto s impact pdf#
Google Patents Purification method of monoclonal antibodiesĭownload PDF Info Publication number CN106380519A CN106380519A CN201610901017.3A CN201610901017A CN106380519A CN 106380519 A CN106380519 A CN 106380519A CN 201610901017 A CN201610901017 A CN 201610901017A CN 106380519 A CN106380519 A CN 106380519A Authority CN China Prior art keywords antibody filler cation exchange chromatography level pad Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.
Google Patents CN106380519A - Purification method of monoclonal antibodies CN106380519A - Purification method of monoclonal antibodies
0 kommentar(er)
